Murphy Canyon Acquisition Corp. (NASDAQ:MURF) announced this afternoon that its special meeting, scheduled for September 13, has been postponed to September 20 at 10:00 a.m., marking the SPAC’s second postponement.
As a result of this change, Murphy Canyon has also extended the redemption deadline for holders of its common stock to 5:00 p.m. ET, on September 18.
At the meeting, MURF stockholders will be asked to vote on a proposal to approve its $700.5 million business combination with drug developer Conduit Pharmaceuticals.
Murphy Canyon inked the deal with Conduit in November 2022. The SPAC originally brought $136 million into the deal from its trust, but saw 83.46% of this redeemed during a January extension meeting, leaving it with $22.6 million post-vote. It has supplemented this with a $27 million PIPE at $10 per share including both new and existing investors.
London-based Conduit is working to develop a range of treatments licensed from AstraZeneca (NASDAQ:AZN) with the aim of exiting these assets following the completion of Phase II trials.
The combined company is expected to trade on the Nasdaq under the symbol “CDT” once the deal is completed.
An In-Depth Look at SPAC Activity Throughout the Third Quarter of 2023 Below is a summary of the year-to-date SPAC performance. We’re now three-quarters of the way through 2023 and while activity remains muted, there is a sense that SPACs have run the most difficult part of the “correction” gauntlet and have reached a better...
Terms Tracker for the Week Ending September 29, 2023 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. As September comes to a close, SPACs did not price any IPOs during the month with the most recent IPO (99 Acquisition Group) having priced...
Athena Consumer Acquisition Corp. (NYSE:ACAQ) announced this afternoon that its stockholders approved its combination with German EV-maker e.GO at a special meeting held earlier today. Additionally, Athena Consumer’s warrant proposal to convert all outstanding warrants to 0.175 shares in the combined company was also approved. A total of 884,880 shares of Athena Class A Common...
October is set to be a quiet month for lock-up expirations with only four de-SPACs and four sponsors now open to trade their shares for the first time. The first customer is Bitdeer Technologies. Its shareholders and the Blue Safari sponsor both stand to gain the most out of this group from moving some of...
Graf Acquisition Corp. IV (NYSE:GFOR) announced in an 8-K this afternoon that its shareholders approved its combination with NKGen Biotech at a special meeting September 25. A total of 3,386,528 shares were redeemed in connection with the vote, leaving Graf IV with about $27.6 million in the tank and a final redemption rate of 84.3%....